DOI QR코드

DOI QR Code

Investigation of pulmonary involvement in inflammatory bowel disease in an experimental model of colitis

  • Aydin, Bunyamin (Division of Endocrinology and Metabolism, Department of Internal Medicine, Suleyman Demirel University Faculty of Medicine) ;
  • Songur, Yildiran (Division of Gastroenterology, Department of Internal Medicine, Memorial Hospital) ;
  • Songur, Necla (Department of Chest Disease, Memorial Hospital) ;
  • Aksu, Oguzhan (Division of Endocrinology and Metabolism, Department of Internal Medicine, Suleyman Demirel University Faculty of Medicine) ;
  • Senol, Altug (Division of Gastroenterology, Department of Internal Medicine, Memorial Hospital) ;
  • Ciris, I. Metin (Department of Pathology, Suleyman Demirel University Faculty of Medicine) ;
  • Sutcu, Recep (Department of Clinical Biochemistry, Suleyman Demirel University Faculty of Medicine)
  • 투고 : 2014.08.06
  • 심사 : 2015.11.25
  • 발행 : 2016.09.01

초록

Background/Aims: Inflammatory bowel disease (IBD) may also involve various extra-intestinal organs. Clinical studies have found asymptomatic/symptomatic pulmonary involvement in 1% to 6% of patients with IBD. The present study histopathologically investigated pulmonary involvement in an experimental model of colitis in order to demonstrate pulmonary tissue involvement in IBD and to expose potential etiological factors. It also explored the relation between inflammation and tissue concentrations of vascular endothelial growth factor (VEGF) and tumor necrosis factor ${\alpha}$ ($TNF-{\alpha}$). Methods: The study comprised 24 male Wistar albino rats. The rats were divided into four groups of six rats each. Acute colitis was induced in two separate groups using either the dextran sulphate sodium (DSS) or trinitrobenzene sulfonic acid (TNBS) method, while the other two groups were used as controls for each model of colitis. Wallace scoring was used for macroscopic assessment of colitis, and the lungs were histopathologically examined. Concentrations of VEGF and $TNF-{\alpha}$ in pulmonary tissue were measured by the enzyme-linked immunosorbent assay method. Results: The number of animals that had alveolar hemorrhage was significantly higher in the TNBS-induced colitis and DSS-induced colitis groups compared to their own control groups (p = 0.015 and p = 0.015, respectively). VEGF and $TNF-{\alpha}$ concentrations in pulmonary tissues were significantly increased in both the TNBS colitis and DSS colitis groups compared to their own control groups (p = 0.002 and p = 0.004, respectively; and p = 0.002 and p = 0.002, respectively). Conclusions: The present study demonstrated that significant and serious histopathological changes directly associated with colitis occur in the lungs in IBD.

키워드

참고문헌

  1. Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am 2002;31:307-327. https://doi.org/10.1016/S0889-8553(01)00019-X
  2. Kraft SC, Earle RH, Roesler M, Esterly JR. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 1976;136:454-459. https://doi.org/10.1001/archinte.1976.03630040056012
  3. Camus P, Piard F, Ashcroft T, Gal AA, Colby TV. The lung in inflammatory bowel disease. Medicine (Baltimore) 1993;72:151-183. https://doi.org/10.1097/00005792-199372030-00003
  4. Higenbottam T, Cochrane GM, Clark TJ, Turner D, Millis R, Seymour W. Bronchial disease in ulcerative colitis. Thorax 1980;35:581-585. https://doi.org/10.1136/thx.35.8.581
  5. Garg K, Lynch DA, Newell JD. Inflammatory airways disease in ulcerative colitis: CT and high-resolution CT features. J Thorac Imaging 1993;8:159-163. https://doi.org/10.1097/00005382-199321000-00010
  6. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-429. https://doi.org/10.1056/NEJMra020831
  7. Sandborn WJ, Targan SR. Biologic therapy of inflammatory bowel disease. Gastroenterology 2002;122:1592-1608. https://doi.org/10.1053/gast.2002.33426
  8. Koutroubakis IE, Tsiolakidou G, Karmiris K, Kouroumalis EA. Role of angiogenesis in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:515-523. https://doi.org/10.1097/00054725-200606000-00012
  9. Le Cras TD, Spitzmiller RE, Albertine KH, Greenberg JM, Whitsett JA, Akeson AL. VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice. Am J Physiol Lung Cell Mol Physiol 2004;287:L134-L142. https://doi.org/10.1152/ajplung.00050.2004
  10. Songur N, Songur Y, Tuzun M, et al. Pulmonary function tests and high-resolution CT in the detection of pulmonary involvement in inflammatory bowel disease. J Clin Gastroenterol 2003;37:292-298. https://doi.org/10.1097/00004836-200310000-00006
  11. Mahadeva R, Walsh G, Flower CD, Shneerson JM. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 2000;15:41-48. https://doi.org/10.1183/09031936.00.15104100
  12. Marvisi M, Borrello PD, Brianti M, Fornarsari G, Marani G, Guariglia A. Changes in the carbon monoxide diffusing capacity of the lung in ulcerative colitis. Eur Respir J 2000;16:965-968. https://doi.org/10.1183/09031936.00.16596500
  13. Fireman Z, Osipov A, Kivity S, et al. The use of induced sputum in the assessment of pulmonary involvement in Crohn’s disease. Am J Gastroenterol 2000;95:730-734. https://doi.org/10.1111/j.1572-0241.2000.01843.x
  14. Kawada M, Arihiro A, Mizoguchi E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol 2007;13:5581-5593. https://doi.org/10.3748/wjg.v13.i42.5581
  15. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803. https://doi.org/10.1016/S0016-5085(89)80079-4
  16. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-249.
  17. Wallace JL, Keenan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physiol 1990;258(4 Pt 1):G527-G534.
  18. Obermeier F, Kojouharoff G, Hans W, Scholmerich J, Gross V, Falk W. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 1999;116:238-245. https://doi.org/10.1046/j.1365-2249.1999.00878.x
  19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
  20. Storch I, Sachar D, Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2003;9:104-115. https://doi.org/10.1097/00054725-200303000-00004
  21. Bewig B, Manske I, Bottcher H, Bastian A, Nitsche R, Folsch UR. Crohn's disease mimicking sarcoidosis in bronchoalveolar lavage. Respiration 1999;66:467-469. https://doi.org/10.1159/000029413
  22. te Velde AA, Verstege MI, Hommes DW. Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm Bowel Dis 2006;12:995-999. https://doi.org/10.1097/01.mib.0000227817.54969.5e
  23. Komai H, Naito Y, Okamura Y. Dextran sulfate as a leukocyte-endothelium adhesion molecule inhibitor of lung injury in pediatric open-heart surgery. Perfusion 2005;20:77-82. https://doi.org/10.1191/0267659105pf788oa
  24. Hocking D, Ferro TJ, Johnson A. Dextran sulfate and heparin sulfate inhibit platelet-activating factor-induced pulmonary edema. J Appl Physiol (1985) 1992;72:179-185. https://doi.org/10.1152/jappl.1992.72.1.179
  25. Gursoy S, Guven K, Kula M, et al. Subclinical alveolar involvement in ulcerative colitis. Inflamm Bowel Dis 2005;11:372-375. https://doi.org/10.1097/01.MIB.0000164019.83666.af
  26. Sandborn WJ, Hanauer SB. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis 1999;5:119-133. https://doi.org/10.1097/00054725-199905000-00008

피인용 문헌

  1. Lung injury as an extra-intestinal manifestation of inflammatory bowel disease vol.31, pp.5, 2016, https://doi.org/10.3904/kjim.2016.266
  2. IL-6 Drives Neutrophil-Mediated Pulmonary Inflammation Associated with Bacteremia in Murine Models of Colitis vol.188, pp.7, 2016, https://doi.org/10.1016/j.ajpath.2018.03.016
  3. Platelet activating factor receptor regulates colitis-induced pulmonary inflammation through the NLRP3 inflammasome vol.12, pp.4, 2016, https://doi.org/10.1038/s41385-019-0163-3
  4. Inflammatory bowel disease and the lung in paediatric patients vol.17, pp.1, 2016, https://doi.org/10.1183/20734735.0269-2020